Does anyone here have any details in regards to ro
Post# of 149715
I know we owe $5M upon first BLA approval and 5% of net sale upon commercialization to Progenics. I take it this will include all Pro 140 sales and not limited to HIV which they originally purchased for. SA article published yesterday reminded me to look into the ABBV payment.
https://seekingalpha.com/article/4249603-prog...ecided-buy
Just trying to determine what a realistic net royalty rate could potentially land on our books?